209 related articles for article (PubMed ID: 36017534)
1. Maximizing mRNA vaccine production with Bayesian optimization.
Rosa SS; Nunes D; Antunes L; Prazeres DMF; Marques MPC; Azevedo AM
Biotechnol Bioeng; 2022 Nov; 119(11):3127-3139. PubMed ID: 36017534
[TBL] [Abstract][Full Text] [Related]
2. mRNA vaccines: the most recent clinical applications of synthetic mRNA.
Kwon S; Kwon M; Im S; Lee K; Lee H
Arch Pharm Res; 2022 Apr; 45(4):245-262. PubMed ID: 35426547
[TBL] [Abstract][Full Text] [Related]
3. Effect of in vitro transcription conditions on yield of high quality messenger and self-amplifying RNA.
Popova PG; Lagace MA; Tang G; Blakney AK
Eur J Pharm Biopharm; 2024 May; 198():114247. PubMed ID: 38462138
[TBL] [Abstract][Full Text] [Related]
4. Increasing yield of in vitro transcription reaction with at-line high pressure liquid chromatography monitoring.
Pregeljc D; Skok J; Vodopivec T; Mencin N; Krušič A; Ličen J; Nemec KŠ; Štrancar A; Sekirnik R
Biotechnol Bioeng; 2023 Mar; 120(3):737-747. PubMed ID: 36471904
[TBL] [Abstract][Full Text] [Related]
5. Development of a capillary zone electrophoresis method to monitor magnesium ion consumption during in vitro transcription for mRNA production.
Wang Y; Li L; Sutton AT; Tu Q; Zhao K; Wen E; Osborn J; Singh A; Gunsch MJ; Rustandi RR; Foley D; He Y
Anal Bioanal Chem; 2024 May; 416(12):2941-2949. PubMed ID: 38594392
[TBL] [Abstract][Full Text] [Related]
6. Flow-NMR as a Process-Monitoring Tool for mRNA IVT Reaction.
Sarkar A; Dong G; Quaglia-Motta J; Sackett K
J Pharm Sci; 2024 Apr; 113(4):900-905. PubMed ID: 38008177
[TBL] [Abstract][Full Text] [Related]
7. Bayesian reaction optimization as a tool for chemical synthesis.
Shields BJ; Stevens J; Li J; Parasram M; Damani F; Alvarado JIM; Janey JM; Adams RP; Doyle AG
Nature; 2021 Feb; 590(7844):89-96. PubMed ID: 33536653
[TBL] [Abstract][Full Text] [Related]
8. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
Kang DD; Li H; Dong Y
Adv Drug Deliv Rev; 2023 Aug; 199():114961. PubMed ID: 37321375
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules.
Zhang J; Liu Y; Li C; Xiao Q; Zhang D; Chen Y; Rosenecker J; Ding X; Guan S
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765153
[TBL] [Abstract][Full Text] [Related]
10. Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.
Martínez J; Lampaya V; Larraga A; Magallón H; Casabona D
Front Mol Biosci; 2023; 10():1248511. PubMed ID: 37842641
[TBL] [Abstract][Full Text] [Related]
11. Current state of, prospects for, and obstacles to mRNA vaccine development.
Aljabali AAA; Bashatwah RM; Obeid MA; Mishra V; Mishra Y; Serrano-Aroca Á; Lundstrom K; Tambuwala MM
Drug Discov Today; 2023 Feb; 28(2):103458. PubMed ID: 36427779
[TBL] [Abstract][Full Text] [Related]
12. mRNA-based therapies: Preclinical and clinical applications.
Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
[TBL] [Abstract][Full Text] [Related]
13. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
[TBL] [Abstract][Full Text] [Related]
14. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
15. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.
Duan LJ; Wang Q; Zhang C; Yang DX; Zhang XY
Front Immunol; 2022; 13():923647. PubMed ID: 35711457
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity.
Loomis KH; Lindsay KE; Zurla C; Bhosle SM; Vanover DA; Blanchard EL; Kirschman JL; Bellamkonda RV; Santangelo PJ
Bioconjug Chem; 2018 Sep; 29(9):3072-3083. PubMed ID: 30067354
[TBL] [Abstract][Full Text] [Related]
17. Messenger RNA-Based Vaccines Against Infectious Diseases.
Alameh MG; Weissman D; Pardi N
Curr Top Microbiol Immunol; 2022; 440():111-145. PubMed ID: 32300916
[TBL] [Abstract][Full Text] [Related]
18. Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity.
Warzak DA; Pike WA; Luttgeharm KD
SLAS Technol; 2023 Oct; 28(5):369-374. PubMed ID: 37833008
[TBL] [Abstract][Full Text] [Related]
19. Anion exchange HPLC monitoring of mRNA
Welbourne EN; Loveday KA; Nair A; Nourafkan E; Qu J; Cook K; Kis Z; Dickman MJ
Front Mol Biosci; 2024; 11():1250833. PubMed ID: 38516194
[TBL] [Abstract][Full Text] [Related]
20. Double-stranded RNA reduction by chaotropic agents during
Piao X; Yadav V; Wang E; Chang W; Tau L; Lindenmuth BE; Wang SX
Mol Ther Nucleic Acids; 2022 Sep; 29():618-624. PubMed ID: 36090758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
